Crossmark

Systematic Optimization, In Vitro Drug Release, and Preliminary Nonclinical Toxicity Assessment of Nonphospholipid-Based Topical Ophthalmic Emulsions Containing 0.05 or 0.1% w/w Cyclosporin A for Dry-Eye Syndrome Management

Crossref DOI link: https://doi.org/10.1208/s12249-019-1587-5

Published Online: 2019-12-26

Published Print: 2020-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rahman, Syed Nazrin Ruhina

Pawde, Datta Maroti

Katari, Oly

Hmingthansanga, Victor

Shunmugaperumal, Tamilvanan https://orcid.org/0000-0001-7338-3207
License Information

Text and Data Mining valid from 2019-12-26

Version of Record valid from 2019-12-26
More Information

Article History

Received: 9 October 2019

Accepted: 20 November 2019

First Online: 26 December 2019

Compliance with Ethical Standards

: The experimental procedure of the hemolysis test was approved by the Ethics Review Committee of Guwahati Neurological Research Center (GNRC) Hospital, Guwahati, Assam, India.

: The authors declare that they have no competing interest.

Document is current

Any future updates will be listed below